Inflammation and the Development of AtherosclerosisYoshiko Mizuno, R. Preston Mason, Robert F. Jacob|Journal of Atherosclerosis and Thrombosis|2011Cited by 163
Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes: Effect of -BlockersR. Preston Mason, Tadeusz Maliñski, Febee Rophail Louka et al.|American Journal of Hypertension|2009Cited by 31
Eicosapentaenoic acid, arachidonic acid, and triglyceride levels mediate most of the benefit of icosapent ethyl in REDUCE-ITMichael Szarek, R. Preston Mason, Patty W. Siri‐Tarino et al.|European Heart Journal|2023Cited by 8
Combined use of calcium channel blockers and inhibitors of the renin–angiotensin system for treating hypertensionYoshiko Mizuno, R. Preston Mason, Robert F. Jacob|Therapy|2011Cited by 2